The way to improve rates of HPV vaccination

National data proves that cervical cancer is possible to prevent by HPV vaccines. A new study from the Moffit Cancer Center focuses on the recommendations on physicians who explain one significant factor which might contribute to low uptake levels. The role of the HPV vaccine is to decrease cervical cancer risk in girls in future age. It is essential to have the vaccine administered before the first sexual experience. “Physician recommendation is central to increasing HPV vaccination rates because it is one of the most important predictors of whether a patient gets the HPV vaccine”, explained Susan T. Vadaparampil, Ph.D., M.P.H., associate member of the Health Outcomes and Behavior Program at Moffitt. The researchers` conclusions are based on surveys between 2009 and 2011 in which physicians were asked how often they recommended the HPV vaccine. Teri L. Malo, Ph.D., M.P.H., a research scientist at Moffitt was also involved in this study. The results of this research are published in the American Journal of Preventive Medicine.